Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2181-2192

  Sharda, Daniel R ^a   Yu, Shan ^a   Ray, Manujendra ^a   Squadrito, Mario Leonardo ^b,c   De Palma, Michele ^b,c   Wynn, Thomas A ^d   Morris Jr , Sidney M ^e   Hankey, Pamela A ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; ARGINASE; COMPLEMENTARY DNA; DECTIN 1; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MANNOSE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C FOS; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE RON; STAT6 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; UPREGULATION;

ANIMALS; ARGINASE; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 80052657814     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003460     Document Type: Article

References (45)

1. Wu, G., and S. M. Morris, Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336: 1-17. (Pubitemid 28532555)
2. Morris, S. M., Jr., D. Kepka-Lenhart, and L.-C. Chen. 1998. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am. J. Physiol. 275: E740-E747.
3. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35. (Pubitemid 37328697)
4. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167: 6533-6544. (Pubitemid 33081589)
5. Pesce, J., T. Ramalingam, M. Mentink-Kane, M. Wilson, K. El Kasmi, A. Smith, R. Thompson, A. Cheever, P. Murray, and T. Wynn. 2009. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 5: e1000393.
6. Thomas, A. C., G. B. Sala-Newby, Y. Ismail, J. L. Johnson, G. Pasterkamp, and A. C. Newby. 2007. Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production. Arterioscler. Thromb. Vasc. Biol. 27: 571-577.
7. Teupser, D., R. Burkhardt, W. Wilfert, I. Haffner, K. Nebendahl, and J. Thiery. 2006. Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler. Thromb. Vasc. Biol. 26: 365-371. (Pubitemid 43732201)
8. El Kasmi, K. C., J. E. Qualls, J. T. Pesce, A. M. Smith, R. W. Thompson, M. Henao-Tamayo, R. J. Basaraba, T. König, U. Schleicher, M. S. Koo, et al. 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9: 1399-1406.
9. Lissbrant, I. F., P. Stattin, P. Wikstrom, J. E. Damber, L. Egevad, and A. Bergh. 2000. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int. J. Oncol. 17: 445-451.
10. Rodriguez, P. C., D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea, M. B. Piazuelo, A. Delgado, P. Correa, J. Brayer, E. M. Sotomayor, et al. 2004. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64: 5839-5849. (Pubitemid 39095585)
11. Zea, A. H., P. C. Rodriguez, M. B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, et al. 2005. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65: 3044-3048. (Pubitemid 40524582)
12. Balkwill, F., K. A. Charles, and A. Mantovani. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217. (Pubitemid 40568680)
13. Bingle, L., N. J. Brown, and C. E. Lewis. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196: 254-265. (Pubitemid 34189413)
14. Pollard, J. W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4: 71-78. (Pubitemid 38082155)
15. Pucci, F., M. A. Venneri, D. Biziato, A. Nonis, D. Moi, A. Sica, C. Di Serio, L. Naldini, and M. De Palma. 2009. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114: 901-914.
16. De Palma, M., M. A. Venneri, R. Galli, L. Sergi Sergi, L. S. Politi, M. Sampaolesi, and L. Naldini. 2005. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226. (Pubitemid 41317592)
17. Wang, M. H., W. Lee, Y. L. Luo, M. T. Weis, and H. P. Yao. 2007. Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells. J. Pathol. 213: 402-411. (Pubitemid 350206512)
18. Zhou, Y. Q., C. He, Y. Q. Chen, D. Wang, and M. H. Wang. 2003. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene 22: 186-197. (Pubitemid 36174176)
19. Maggiora, P., S. Marchio, M. C. Stella, M. Giai, A. Belfiore, M. De Bortoli, M. F. Di Renzo, A. Costantino, P. Sismondi, and P. M. Comoglio. 1998. Overexpression of the RON gene in human breast carcinoma. Oncogene 16: 2927-2933. (Pubitemid 28383277)
20. Welm, A. L., J. B. Sneddon, C. Taylor, D. S. Nuyten, M. J. Van de Vijver, B. H. Hasegawa, and J. M. Bishop. 2007. The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc. Natl. Acad. Sci. USA 104: 7570-7575. (Pubitemid 47185947)
21. Kretschmann, K. L., H. Eyob, S. S. Buys, and A. L. Welm. 2010. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression. Curr. Drug Targets 11: 1157-1168.
22. Morrison, A. C., C. B. Wilson, M. Ray, and P. H. Correll. 2004. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J. Immunol. 172: 1825-1832. (Pubitemid 38116831)
23. Liu, Q. P., K. Fruit, J. Ward, and P. H. Correll. 1999. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 163: 6606-6613.
24. Wilson, C. B., M. Ray, M. Lutz, D. Sharda, J. Xu, and P. A. Hankey. 2008. The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity. J. Immunol. 181: 2303-2310.
25. Ray, M., S. Yu, D. Sharda, C. Wilson, Q. Liu, N. Kaushal, K. Prabhu, and P. Hankey. 2010. Inhibition of TLR4-induced IkappaB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage stimulating protein. J. Immunol. 185: 7309-7316.
26. Tsutsui, S., F. Noorbakhsh, A. Sullivan, A. J. Henderson, K. Warren, K. Toney-Earley, S. E. Waltz, and C. Power. 2005. RON-regulated innate immunity is protective in an animal model of multiple sclerosis. Ann. Neurol. 57: 883-895. (Pubitemid 40798627)
27. Lentsch, A. B., P. Pathrose, S. Kader, S. Kuboki, M. H. Collins, and S. E. Waltz. 2007. The Ron receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor kappaB activation. Shock 27: 274-280.
28. Correll, P. H., A. Iwama, S. Tondat, G. Mayrhofer, T. Suda, and A. Bernstein. 1997. Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct. 1: 69-83.
29. Morrison, A. C., and P. H. Correll. 2002. Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J. Immunol. 168: 853-860. (Pubitemid 34049588)
30. Gray, M. J., M. Poljakovic, D. Kepka-Lenhart, and S. M. Morris Jr. 2005. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene 353: 98-106. (Pubitemid 40805364)
31. Wei, X., S. Ni, and P. H. Correll. 2005. Uncoupling ligand-dependent and -independent mechanisms for mitogen-activated protein kinase activation by the murine Ron receptor tyrosine kinase. J. Biol. Chem. 280: 35098-35107. (Pubitemid 41532696)
32. Wei, X., L. Hao, S. Ni, Q. Liu, J. Xu, and P. H. Correll. 2005. Altered exon usage in the juxtamembrane domain of mouse and human RON regulates receptor activity and signaling specificity. J. Biol. Chem. 280: 40241-40251. (Pubitemid 41779162)
33. Pauleau, A. L., R. Rutschman, R. Lang, A. Pernis, S. S. Watowich, and P. J. Murray. 2004. Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 172: 7565-7573. (Pubitemid 38747620)
34. Lock, L. S., M. M. Frigault, C. Saucier, and M. Park. 2003. Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain. J. Biol. Chem. 278: 30083-30090. (Pubitemid 36962400)
35. Lock, L. S., I. Royal, M. A. Naujokas, and M. Park. 2000. Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J. Biol. Chem. 275: 31536-31545.
36. Teal, H. E., S. Ni, J. Xu, L. D. Finkelstein, A. M. Cheng, R. F. Paulson, G. S. Feng, and P. H. Correll. 2006. GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells. Oncogene 25: 2433-2443.
37. Daley, J. M., S. K. Brancato, A. A. Thomay, J. S. Reichner, and J. E. Albina. 2010. The phenotype of murine wound macrophages. J. Leukoc. Biol. 87: 59-67.
38. Zhu, W., U. M. Chandrasekharan, S. Bandyopadhyay, S. M. Morris, Jr., P. E. DiCorleto, and V. S. Kashyap. 2010. Thrombin induces endothelial arginase through AP-1 activation. Am. J. Physiol. Cell Physiol. 298: C952-C960.
39. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
40. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
41. Auffray, C., D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, A. Cumano, G. Lauvau, and F. Geissmann. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670. (Pubitemid 47229966)
42. Rauh, M. J., V. Ho, C. Pereira, A. Sham, L. M. Sly, V. Lam, L. Huxham, A. I. Minchinton, A. Mui, and G. Krystal. 2005. SHIP represses the generation of alternatively activated macrophages. Immunity 23: 361-374. (Pubitemid 41443438)
43. Sinha, P., V. K. Clements, and S. Ostrand-Rosenberg. 2005. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174: 636-645. (Pubitemid 40094255)
44. Ozao-Choy, J., G. Ma, J. Kao, G. X. Wang, M. Meseck, M. Sung, M. Schwartz, C. M. Divino, P. Y. Pan, and S. H. Chen. 2009. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 69: 2514-2522.
45. Xin, H., C. Zhang, A. Herrmann, Y. Du, R. Figlin, and H. Yu. 2009. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 69: 2506-2513.